Comments: US HB6710 | 2021-2022 | 117th Congress
Bill Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
Spectrum: Partisan Bill (Republican 21-0)
Status: (Introduced - Dead) 2022-02-14 - Referred to the Subcommittee on Health. [HB6710 Detail]
Text: Latest bill text (Introduced) [PDF]
Spectrum: Partisan Bill (Republican 21-0)
Status: (Introduced - Dead) 2022-02-14 - Referred to the Subcommittee on Health. [HB6710 Detail]
Text: Latest bill text (Introduced) [PDF]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress HB6710 at this time. |